MAPKinase gene expression, as determined by microarray analysis, distinguishes uncomplicated from complicated reconstitution after major surgical trauma

Annals of the New York Academy of Sciences

Volumn 1090, Issue , 2006, Pages 429-444

  Schneider, E Marion ^a   Weiss, Manfred ^a   Du, Weidong ^a   Leder, Gerhard ^a   Buttenschön, Klaus ^a   Liener, Ulrich C ^a   Brückner, Uwe B ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Cytokines; Hematopoiesis; Microarray; Outcome; Reconstitution; Sepsis, MAP kinase; Tissue regeneration; Transcription factors; Trauma induced gene expression

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CD27 ANTIGEN; CD3 ANTIGEN; CHEMOKINE; LIPOXYGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 7; PERFORIN; PROTEIN S 100; TRANSCRIPTION FACTOR RUNX1; MESSENGER RNA; TRANSCRIPTION FACTOR;

ADULT; AGED; CELL MATURATION; CONFERENCE PAPER; DENDRITIC CELL; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENETIC SCREENING; HEMATOPOIESIS; HUMAN; MAJOR SURGERY; MICROARRAY ANALYSIS; NATURAL KILLER T CELL; SEPTIC SHOCK; SURGICAL INJURY; SURGICAL PATIENT; SURGICAL STRESS; TISSUE DEGENERATION; TISSUE REGENERATION; TRANSCRIPTION REGULATION; UPREGULATION; ARTICLE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; INJURY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SURGERY;

ADULT; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SURGICAL PROCEDURES, OPERATIVE; TRANSCRIPTION FACTORS; WOUNDS AND INJURIES;

EID: 34247602553     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1378.046     Document Type: Conference Paper

References (51)

1. PERL, M., F. GEBHARD, M.W. KNOFERL, et al. 2003. The pattern of preformed cytokines in tissues frequently affected by blunt trauma. Shock 19: 299-304.
2. KEHLET, H. 1997. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br. J. Anaesth. 78: 606-617.
3. MATZINGER, P. 2002. An innate sense of danger. Ann. N. Y. Acad. Sci. 961: 341-342.
4. FRIEDERICH, P. 2003. Basic concepts of ion channel physiology and anaesthetic drug effects. Eur. J. Anaesthesiol. 20: 343-353.
5. BRAND, J.M., C. FROHN, J. LUHM, et al. 2003. Early alterations in the number of circulating lymphocyte subpopulations and enhanced proinflammatory immune response during opioid-based general anesthesia. Shock 20: 213-217.
6. LIENER, U.C., U.B. BRUCKNER, M.W. KNOFERL, et al. 2002. Chemokine activation within 24 hours after blunt accident trauma. Shock 17: 169-172.
7. PATHAN, N., C.A. HEMINGWAY, A.A. ALIZADEH, et al. 2004. Role of interleukin 6 inmyocardial dysfunction of meningococcal septic shock. Lancet 363: 203-209.
8. PRUCHA, M., A. RURYK, H. BORISS, et al. 2004. Expression profiling: toward an application in sepsis diagnostics. Shock 22: 29-33.
9. TABRIZI, A.R., B.A. ZEHNBAUER, B.D. FREEMAN, et al. 2001. Genetic markers in sepsis. J. Am. Coll. Surg. 192: 106-117; quiz 145-146.
10. KNIGHT, P.R., A. SREEKUMAR, J. SIDDIQUI, et al. 2004. Development of a sensitive microarray immunoassay and comparison with standard enzyme-linked immunoassay for cytokine analysis. Shock 21: 26-30.
11. WARD, P.A. 2004. The dark side of C5a in sepsis. Nat. Rev. Immunol. 4: 133-142.
12. CHINNAIYAN, A.M., M. HUBER-LANG, C. KUMAR-SINHA, et al. 2001. Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation. Am. J. Pathol. 159: 1199-1209.
13. WHITNEY, A.R., M. DIEHN, S.J. POPPER, et al. 2003. Individuality and variation in gene expression patterns in human blood. Proc. Natl. Acad. Sci. USA 100: 1896-1901.
14. ROSENWALD, A., G. WRIGHT, W.C. CHAN, et al. 2002. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346: 1937-1947.
15. BULLINGER, L., K. DOHNER, E. BAIR, et al. 2004. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N. Engl. J. Med. 350: 1605-1616.
16. GOLUB, T.R. 2003. Mining the genome for combination therapies. Nat. Med. 9: 510-511.
17. COBB, J.P. & T.G. BUCHMAN. 2001. MicroArRAY of hope. Shock 16: 264-265.
18. PETRICOIN, E.F. 3RD, J.L. HACKETT, L.J. LESKO, et al. 2002. Medical applications of microarray technologies: a regulatory science perspective. Nat. Genet. 32(Suppl.): 474-479.
19. MCGILVRAY, I.D., V. TSAI, J.C. MARSHALL, et al. 2002. Monocyte adhesion and transmigration induce tissue factor expression: role of the mitogen-activated protein kinases. Shock 18: 51-57.
20. GEORGESCU, S.P., I. KOMURO, Y. HIROI, et al. 1997. Downregulation of polo-like kinase correlates with loss of proliferative ability of cardiac myocytes. J. Mol. Cell Cardiol. 29: 929-937.
21. JOHNSON, M.E., J.C. SILL, C.B. UHL, et al. 1996. Effect of volatile anesthetics on hydrogen peroxide-induced injury in aortic and pulmonary arterial endothelial cells. Anesthesiology 84: 103-116.
22. KHADAROO, R.G., J. PARODO, K.A. POWERS, et al. 2003. Oxidant-induced priming of the macrophage involves activation of p38 mitogen-activated protein kinase through an Src-dependent pathway. Surgery 134: 242-246.
23. KHADAROO, R.G., R. HE, J. PARODO, et al. 2004. The role of the Src family of tyrosine kinases after oxidant-induced lung injury in vivo. Surgery 136: 483-488.
24. ZHANG, D., J. LI, Z. JIANG, et al. 2003. The relationship between tumor necrosis factor-alpha gene polymorphisms and acute severe pancreatitis. Chin. Med. J. (Engl.) 116: 1779-1781.
25. O'SUILLEABHAIN, C.B., S. KIM, M.R. RODRICK, et al. 2001. Injury induces alterations in T-cell NFkappaB and AP-1 activation. Shock 15: 432-437.
26. CHEN, D., L.G. XU, L. CHEN, et al. 2003. NIK is a component of the EGF/heregulin receptor signaling complexes. Oncogene 22: 4348-4355.
27. REGAN, C.P., W. LI, D.M. BOUCHER, et al. 2002. Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. Proc. Natl. Acad. Sci. USA 99: 9248-9253.
28. DINEV, D., B.W. JORDAN, B. NEUFELD, et al. 2001. Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep. 2: 829-834.
29. LEE, K.S., S.H. HONG & S.C. BAE. 2002. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene 21: 7156-7163.
30. ZHANG, X., Z. CHEN, H. HUANG, et al. 2002. DNA microarray analysis of the gene expression profiles of naive versus activated tumor-specific T cells. Life Sci. 71: 3005-3017.
31. TATSUYAMA, K., Y. MAEZAWA, H. BABA, et al. 2000. Expression of various growth factors for cell proliferation and cytodifferentiation during fracture repair of bone. Eur. J. Histochem. 44: 269-278.
32. CALVO, S., J. STAUFFER, M. NAKAYAMA, et al. 1996. Transcriptional control of muscle plasticity: differential regulation of troponin I genes by electrical activity. Dev. Genet. 19: 169-181.
33. LIU, L., J.E. CAVANAUGH, Y. WANG, et al. 2003. ERK5 activation of MEF2-mediated gene expression plays a critical role in BDNF-promoted survival of developing but not mature cortical neurons. Proc. Natl. Acad. Sci. USA 100: 8532-8537.
34. GARCIA-LORA, A., M. MARTINEZ, S. PEDRINACI, et al. 2003. Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line. Cancer Immunol. Immunother. 52: 59-64.
35. LIU, L.X., Z.H. LIU, H.C. JIANG, et al. 2003. Gene expression profiles of hepatoma cell line HLE. World J. Gastroenterol. 9: 683-687.
36. NOMIYAMA, H., S. FUKUDA, M. IIO, et al. 1999. Organization of the chemokine gene cluster on human chromosome 17q11.2 containing the genes for CC chemokine MPIF-1, HCC-2, HCC-1, LEC, and RANTES. J. Interferon. Cytokine. Res. 19: 227-234.
37. OBATA-ONAI, A., S. HASHIMOTO, N. ONAI, et al. 2002. Comprehensive gene expression analysis of human NK cells and CD8(+) T lymphocytes. Int. Immunol. 14: 1085-1098.
38. GODSHALL, C.J., M.J. SCOTT, P.T. BURCH, et al. 2003. Natural killer cells participate in bacterial clearance during septic peritonitis through interactions with macrophages. Shock 19: 144-149.
39. DIAS, A.A., A.R. GOODMAN, J.L. DOS SANTOS, et al. 2001. TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis. J. Leukoc. Biol. 69: 928-936.
40. EFRON, P. & L.L. MOLDAWER. 2003. Sepsis and the dendritic cell. Shock 20: 386-401.
41. FRIES, M., D. KUNZ, A.M. GRESSNER, et al. 2003. Procalcitonin serum levels after out-of-hospital cardiac arrest. Resuscitation 59: 105-109.
42. SCHNEEMILCH, C.E. & U. BANK. 2001. Release of pro- and anti-inflammatory cytokines during different anesthesia procedures. Anaesthesiol. Reanim. 26: 4-10.
43. GILLILAND, H.E., M.A. ARMSTRONG, U. CARABINE, et al. 1997. The choice of anesthetic maintenance technique influences the antiinflammatory cytokine response to abdominal surgery. Anesth. Analg. 85: 1394-1398.
44. ANGELASTRO, J.M., T.N. IGNATOVA, V.G. KUKEKOV, et al. 2003. Regulated expression of ATF5 is required for the progression of neural progenitor cells to neurons. J. Neurosci. 23: 4590-4600.
45. PETERS, C.S., X. LIANG, S. LI, et al. 2001. ATF-7, a novel bZIP protein, interacts with the PRL-1 protein-tyrosine phosphatase. J. Biol. Chem. 276: 13718-13726.
46. FARMER, P. & J. PUGIN. 2000. Beta-adrenergic agonists exert their "antiinflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway. Am. J. Physiol. Lung. Cell Mol. Physiol. 279: L675-L682.
47. HAMAYA, Y., T. TAKEDA, S. DOHI, et al. 2000. The effects of pentobarbital, isoflurane, and propofol on immediate-early gene expression in the vital organs of the rat. Anesth. Analg. 90: 1177-1183.
48. WELTERS, I.D., A. MENZEBACH, Y. GOUMON, et al. 2000. Morphine inhibits NF-kappaB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism. Anesthesiology 92: 1677-1684.
49. ELENKOV, I.J., D.A. PAPANICOLAOU, R.L. WILDER, et al. 1996. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Physicians 108: 374-381.
50. STEER, J.H., K.M. KROEGER, L.J. ABRAHAM, et al. 2000. Glucocorticoids suppress tumor necrosis factor-alpha expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kappa B and c-Jun-activating transcription factor-2 binding sites in the promoter. J. Biol. Chem. 275: 18432-18440.
51. PAVLICKOVA, P., E.M. SCHNEIDER & H. HUG. 2004. Advances in recombinant antibody microarrays. Clin. Chim. Acta 343: 17-35.